Return On Equity in % of BioAge Labs, Inc. from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioAge Labs, Inc. quarterly/annual Return On Equity history and growth rate from 2023 to Q3 2025.
  • BioAge Labs, Inc. Return On Equity for the quarter ending September 30, 2025 was -25.1 %, a 121% decline year-over-year.
  • BioAge Labs, Inc. annual Return On Equity for 2024 was -112 %, a 358% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

BioAge Labs, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -25.1 -142 -121% Jul 1, 2025 Sep 30, 2025
Q2 2025 -25.4 -60.5 -172% Apr 1, 2025 Jun 30, 2025
Q1 2025 -37.7 -78.1 -193% Jan 1, 2025 Mar 31, 2025
Q4 2024 -112 -155 -358% Oct 1, 2024 Dec 31, 2024
Q3 2024 117 Jul 1, 2024 Sep 30, 2024
Q2 2024 35.1 Apr 1, 2024 Jun 30, 2024
Q1 2024 40.4 Jan 1, 2024 Mar 31, 2024
Q4 2023 43.4 Oct 1, 2023 Dec 31, 2023

BioAge Labs, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -112 -155 -358% Jan 1, 2024 Dec 31, 2024
2023 43.4 Jan 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.